Hong Kong Fintech News, Cryptocurrency Stories, Business Press Releases

Degen Announces Release of Rocketcoin

DUBAI, UAE, May 22, 2023 – (ACN Newswire via SEAPRWire.com) – A new meme coin frenzy has been all set to roll-out in May where we shall see a 0 Tax trading token making headlines in the meme space in the crypto market. Lauded primarily for its no stealth launch and allowing equal opportunity to […]

Mitsubishi Shipbuilding and Nihon Shipyard Launch Joint Study for Development of an Ocean-Going LCO2 Carrier

TOKYO, May 22, 2023 – (JCN Newswire via SEAPRWire.com) – Mitsubishi Shipbuilding, a part of Mitsubishi Heavy Industries (MHI) Group and Nihon Shipyard Co., Ltd., a Tokyo-based joint venture for ship design and sales between Imabari Shipbuilding Co., Ltd. and Japan Marine United Corporation have started joint study for the development of an ocean-going liquified […]

Baguio wins an AI-powered Government Smart Toilet contract servicing at over 800 public toilets in Hong Kong

Baguio wins an AI-powered Government Smart Toilet contract servicing at over 800 public toilets in Hong Kong

HONG KONG, May 22, 2023 – (ACN Newswire via SEAPRWire.com) – Baguio Green Group Limited (“Baguio” or the “Company”, Stock Code: 01397.HK) is pleased to announce that it has been awarded a 2-year service contract (“Contract”), by the Food and Environmental Hygiene Department of the HKSAR Government (“the Government”) for the provision of People Counter […]

Green energy plays bigger roles in European countries

A herd of sheep take a rest under solar panels of the Francisco Pizarro photovoltaic power plant in Caceres, Spain, on March 24, 2023. (PHOTO / XINHUA) LISBON – European countries have been accelerating their green transition by promoting usage of renewable sources such as wind and solar. Recent data showed that the rates of […]

SpaceX launches private passengers to space station

A SpaceX Falcon 9 rocket, with the Dragon capsule and a crew of four private astronauts, lifts off from pad 39A, at the Kennedy Space Center in Cape Canaveral, Florida, May 21, 2023. (PHOTO / AP) LOS ANGELES – US private space company SpaceX launched another crew of private astronauts to the International Space Station […]

Sinn Fein wins most seats in N. Ireland local elections

This file photo shows Sinn Fein's Vice-President Michelle O'Neill speaks to the media at Parliament Buildings, Stormont, Belfast, on May 9, 2022. (PHOTO / AP) LONDON – Irish nationalist party Sinn Fein won the most seats in Northern Ireland's local elections, according to the full tally released on Sunday. People across Northern Ireland voted on […]

Sudan’s army backs short-term ceasefire deal

A Sudanese army armoured vehicle is stationed in southern Khartoum on May 21, 2023. (PHOTO / AFP) KHARTOUM – The Sudanese Army announced on Sunday its commitment to the Agreement on a Short-Term Ceasefire and Humanitarian Arrangements it signed with the Rapid Support Forces (RSF) in the Saudi Arabian port city of Jeddah late Saturday. […]

Tokyo Tech, Tohoku University, Fujitsu, and RIKEN start collaboration to develop distributed training of Large Language Models

TOKYO, May 22, 2023 – (JCN Newswire via SEAPRWire.com) – Tokyo Institute of Technology (Tokyo Tech), Tohoku University, Fujitsu Limited, and RIKEN today announced that they will embark on the research and development of a distributed training of Large Language Models (LLM) (1) on supercomputer Fugaku in May 2023, within the scope of the initiatives […]

SinoMab Announces IND Application of SM17 for the Treatment of Asthma was Accepted by NMPA CDE

HONG KONG, May 22, 2023 – (ACN Newswire via SEAPRWire.com) – A Hong Kong-based biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases – SinoMab BioScience Limited (Stock Code: 3681.HK, “SinoMab” or the “Company”), is pleased to announce that an Investigational New Drug (“IND”) application for […]

Neurimmune: Promising Phase 1 Results for Antibody NI006 in ATTR Cardiomyopathy Published in the New England Journal of Medicine

ZURICH, SWITZERLAND, May 22, 2023 – (ACN Newswire via SEAPRWire.com) – Neurimmune announced today that primary results of its Phase 1 proof-of-concept study of NI006, a recombinant human antibody to deplete amyloid deposits in ATTR cardiomyopathy, have been presented in Prague at Heart Failure 2023, a scientific congress of the European Society of Cardiology (ESC), […]

SinoMab Announces IND Application of SM17 for the Treatment of Asthma was Accepted by NMPA CDE

HONG KONG, May 22, 2023 – (ACN Newswire via SEAPRWire.com) – A Hong Kong-based biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases – SinoMab BioScience Limited (Stock Code: 3681.HK, “SinoMab” or the “Company”), is pleased to announce that an Investigational New Drug (“IND”) application for […]

Greek conservatives win general elections, fall short of majority

Greece's Prime Minister and leader of New Democracy Kyriakos Mitsotakis addresses supporters at the headquarters of his party in Athens, Greece, May 21, 2023. The conservative party of Greek Prime Minister Kyriakos Mitsotakis has won a landslide election but without enough parliamentary seats to form a government. (PHOTO / AP) ATHENS – Greek conservatives received […]

Eisai Submits Marketing Authorization Application for Lecanemab as Treatment for Early Alzheimer’s Disease in Great Britain

TOKYO, May 20, 2023 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. and Biogen Inc. announced today that Eisai has submitted a Marketing Authorization Application (MAA) for lecanemab, an investigational anti-amyloid beta (Aβ) protofibril antibody, for the treatment of early Alzheimer’s disease (mild cognitive impairment due to Alzheimer’s disease (AD) and mild AD dementia) […]

SinoMab Annouces IND Application of SM17 for the Treatment of Asthma was Accepted by NMPA CDE

HONG KONG, May 22, 2023 – (ACN Newswire via SEAPRWire.com) – A Hong Kong-based biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases – SinoMab BioScience Limited (Stock Code: 3681.HK, “SinoMab” or the “Company”), is pleased to announce that an Investigational New Drug (“IND”) application for […]